Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Wall Street Unhappy With Mindray Medical’s Q3
Nov 11, 2008 02:13 PM
- Earnings Review: 10th November
Nov 10, 2008 11:21 PM
- Periodicals Wrap-Up for Monday, June 23rd
Jun 23, 2008 10:22 AM
- ChinaBio: Week in Review: Deals and Drugs
Jun 15, 2008 03:47 PM
- Mindray Receives US Clearance for Two Products
Jun 13, 2008 05:56 PM
- The Week in Review: What’s Not to Like in China Biopharma?
May 11, 2008 01:22 AM
- Mindray Tops Estimates in Q1
May 09, 2008 01:27 PM
- 77 Stocks Returning 12%+ this Week
Apr 06, 2008 10:16 PM
- China Biopharma Stocks Suffer Tough First Quarter
Apr 02, 2008 12:22 AM
- 81 Stock Returning 9%+ this Week
Mar 31, 2008 05:35 AM
- Mindray Medical to Exhibit at RSNA 2008 in Chicago, from November 30th to December 4th, 2008
Nov 19, 2008 09:02 AM
- Mindray Medical to Exhibit at MEDICA 2008 in Dusseldorf, Germany from November 19th to 22nd, 2008
Nov 17, 2008 09:55 AM
- Seven Summits Research Releases Alerts on RIMM, JPM, SGP, BG, and MR
Nov 11, 2008 09:31 AM
- Mindray Announces 2008 Third Quarter and Nine Months Results
Nov 10, 2008 05:01 PM
- Mindray Medical's Datascope Patient Monitoring Division Renews GPO Contract with Health Trust Purchasing Group
Oct 23, 2008 08:02 AM
- Mindray to Report Third Quarter 2008 Financial Results on November 11, 2008
Oct 22, 2008 05:00 AM
- Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair
Oct 21, 2008 07:31 AM
- Mindray Appoints Mr. Peter Wan and Mr. Kern Lim to Board of Directors
Sep 29, 2008 10:50 AM
- Mindray to Hold Annual General Meeting in Hong Kong on October 17, 2008
Sep 16, 2008 05:00 PM
- Mindray Medical International Announces Second Quarter 2008 Results
Sep 03, 2008 06:12 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
MR
|
Compare to S&P
|
| YTD |
-61.79 %
|
-28.35 %
|
| 4 Weeks |
-25.40 %
|
-17.06 %
|
| 12 Weeks |
-57.70 %
|
-32.79 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -6.90 %
|
|
EPS Growth in Last Year: 42.11 %
|
|
Sales Growth in Last Quarter: 0.59 %
|
|
Sales Growth in Last Quarter: 91.53 %
|
|
|
